Literature DB >> 24168412

Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease.

Mariska Meijer1, Ger T Rijkers, Frans J van Overveld.   

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by a decreased airflow due to airway narrowing that, once it occurs, is not fully reversible. The disease usually is progressive and associated with an enhanced inflammatory response in the lungs after exposure to noxious particles or gases. After removal of the noxious particles, the inflammation can continue in a self-sustaining manner. It has been established that improper activation of neutrophils lies at the core of the pathology. This paper provides an overview of the mechanisms by which neutrophils can induce the pulmonary damage of COPD. As the pathogenesis of COPD is slowly being unraveled, new points of intervention are discovered, some of which with promising results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24168412     DOI: 10.1586/1744666X.2013.851347

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  29 in total

1.  IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis.

Authors:  Malcolm R Starkey; Maximilian W Plank; Paolo Casolari; Alberto Papi; Stelios Pavlidis; Yike Guo; Guy J M Cameron; Tatt Jhong Haw; Anthony Tam; Ma'en Obiedat; Chantal Donovan; Nicole G Hansbro; Duc H Nguyen; Prema Mono Nair; Richard Y Kim; Jay C Horvat; Gerard E Kaiko; Scott K Durum; Peter A Wark; Don D Sin; Gaetano Caramori; Ian M Adcock; Paul S Foster; Philip M Hansbro
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671

2.  Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties.

Authors:  Huifeng Yu; Anabel Gonzalez-Gil; Yadong Wei; Steve M Fernandes; Ryan N Porell; Katarina Vajn; James C Paulson; Corwin M Nycholat; Ronald L Schnaar
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

3.  Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.

Authors:  Chhinder P Sodhi; Christine Wohlford-Lenane; Yukihiro Yamaguchi; Thomas Prindle; William B Fulton; Sanxia Wang; Paul B McCray; Mark Chappell; David J Hackam; Hongpeng Jia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

4.  Multi-omic profiling of primary mouse neutrophils predicts a pattern of sex and age-related functional regulation.

Authors:  Ryan J Lu; Shalina Taylor; Kévin Contrepois; Minhoo Kim; Juan I Bravo; Mathew Ellenberger; Nirmal K Sampathkumar; Bérénice A Benayoun
Journal:  Nat Aging       Date:  2021-07-19

Review 5.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

Review 6.  Neutrophils as emerging therapeutic targets.

Authors:  Tamás Németh; Markus Sperandio; Attila Mócsai
Journal:  Nat Rev Drug Discov       Date:  2020-01-22       Impact factor: 84.694

7.  S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.

Authors:  David C L Lam; Stanley C H Chan; Judith C W Mak; Craig Freeman; Mary S M Ip; Daisy K Y Shum
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

Review 8.  Lung inflammation caused by inhaled toxicants: a review.

Authors:  John Wong; Bruce E Magun; Lisa J Wood
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-23

9.  Effects of Chung-Pae Inhalation Therapy on a Mouse Model of Chronic Obstructive Pulmonary Disease.

Authors:  Joon-Ho Hwang; Beom-Joon Lee; Hee Jae Jung; Kwan-Il Kim; Jun-Yong Choi; Myungsoo Joo; Sung-Ki Jung
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

10.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.